Certara
NASDAQ: CERTRadnor, US · Founded 2017 · Delaware corporation · 1,490 employees on LinkedIn · 2 known investors
Find your way into Certara
2,386 people in our graph share verified history with the Certara team — schools, employers, funds. One of them is your warm intro.
Wesley Chanunlockedknows William Feehery · together at Massachusetts Institute of Technology (overlapped)
×2knows the team · via Massachusetts Institute of Technology
knows the team · via Chief
knows the team · via Stanford University
knows the team · via Nexthink
knows the team · via Stanford University Graduate School of Business
Certara provides biosimulation software, modeling, and regulatory services that support drug discovery and development across discovery, preclinical, clinical, regulatory, and market access phases. It serves pharmaceutical and biotech organizations seeking to make data-driven decisions and streamline regulatory submissions.
Founders & leadership
AM
Adrian McKemeyinPresidentAdrian McKemey holds a Ph.D. in High Energy Nuclear Particle Physics from the University of London and has spent 25+ years in drug development and life sciences strategy, including roles as a Principal at Boston Consulting Group, Head of R&D Strategy Solutions at Quintiles, and Vice President of Enterprise Transformation at IQVIA, before becoming President of Certara Drug Development Solutions.
RA
Rona AnhaltinChief Human Resources OfficerShe has held HR leadership roles across biotech, pharma, and technology companies, with experience scaling HR systems during growth phases, managing organizational change, and building leadership teams.
DC
Daniel CorcoraninSenior Vice President and General CounselDaniel Corcoran is SVP and General Counsel at Certara, a biosimulation and regulatory services company. He previously practiced corporate law at Sullivan & Cromwell in New York and Frankfurt, and has served as General Counsel at multiple private and public companies in AI and SaaS sectors.
LP
Leif PederseninPresident, Chief Commercial OfficerLeif Pedersen is President and Chief Commercial Officer at Certara, a provider of biosimulation software and regulatory services for drug development. He brings over 35 years of software industry experience across sales, product, R&D, and operations at companies including Dassault Systemes, Accelrys Software, Siemens, Oracle, and others.
WF
William FeeheryinCEOWilliam Feehery is CEO and Director of Certara, a company providing biosimulation software, modeling, and regulatory services to support pharmaceutical and biotech organizations throughout drug discovery and development.
JW
Jieun W. ChoeinChief Strategy and Marketing Officer2020–2022Chief Strategy & Marketing Officer at Certara, which provides biosimulation software and regulatory services for pharmaceutical drug development. Experienced executive who has led strategy and operations at venture and private-equity-backed growth-stage technology companies.
RM
Richard M. TraynorinConsultantRichard M. Traynor is Senior Vice President and General Counsel at Certara. He brings over 25 years of legal and executive experience in technology and life sciences at both public and private companies, with expertise spanning securities law, M&A, regulatory compliance, and data privacy.
CR
Craig R. RaynerPresident, Integrated Drug Development
JE
Justin EdgeinPresident, Regulatory & Access2019–2022Justin Edge is President of Regulatory and Access at Certara, a provider of biosimulation software and regulatory services for pharmaceutical and biotech companies. He brings experience in regulatory and market access functions across life sciences, with involvement in multiple M&A and corporate transactions.
ND
Nicolette D. ShermaninChief Human Resources Officer2021–2024Nicolette D. Sherman is Chief Human Resources Officer at Certara, a biosimulation and regulatory services company serving the pharmaceutical and biotech sectors. She has held senior HR leadership roles at Oyster Point Pharma, Sanofi, and Schering-Plough, with experience in talent management, organizational development, and workforce planning.
JR
Jon ResnickinCEOCEO of Certara, a biosimulation software and regulatory services provider for drug development. Healthcare executive with experience leading global teams and building businesses focused on data-driven solutions in life sciences.
JE
John E. Gallagher IIISenior Vice President and Chief Financial Officer
Investors · 2
Reported raises · per SEC filings
Form D private placements$14.3M disclosed across 2 of 4 rounds · 2021–2026
▶$8.6MraisedApr 2026 · 6 investors · Other Health CareRule 506(b)
▶$8.6MraisedApr 2026 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Rona AnhaltExecutive Officer
- Cynthia CollinsDirector
- Eran BroshyDirector
- Matthew WalshDirector
- Stephen McLeanDirector
- James CashmanDirector
- David SpaightDirector
- John Gallagher IIIExecutive Officer
- Nancy KilleferDirector
- Daniel CorcoranExecutive Officer
- Arjun BediDirector
- Rosemary CraneDirector
- Robert AspburyExecutive Officer
- John ReyndersDirector
- Leif PedersenExecutive Officer
- Adrian McKemeyExecutive Officer
- Jon ResnickExecutive Officer, Director
- Amount sold
- $8.6M
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.7MraisedMar 2025 · 6 investors · Other Health CareRule 506(b)
▶$5.7MraisedMar 2025 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John Gallagher IIIExecutive Officer
- Adrian McKemeyExecutive Officer
- Rona AnhaltExecutive Officer
- Cynthia CollinsDirector
- Daniel CorcoranExecutive Officer
- John ReyndersDirector
- Stephen McLeanDirector
- Matthew WalshDirector
- Robert AspburyExecutive Officer
- Eran BroshyDirector
- Leif PedersenExecutive Officer
- William FeeheryExecutive Officer, Director
- David SpaightDirector
- Rosemary CraneDirector
- James CashmanDirector
- Nancy KilleferDirector
- Amount sold
- $5.7M
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶Undisclosed amountofferedMar 2024 · BiotechnologyRule 506(b)
▶Undisclosed amountofferedMar 2024 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Cynthia CollinsDirector
- Patrick SmithExecutive Officer
- Rosemary CraneDirector
- Nancy KilleferDirector
- Nicolette ShermanExecutive Officer
- Eran BroshyDirector
- Matthew WalshDirector
- Stephen McLeanDirector
- John Gallagher IIIExecutive Officer
- Robert AspburyExecutive Officer
- David SpaightDirector
- William FeeheryExecutive Officer, Director
- Leif PedersenExecutive Officer
- James Cashman IIIDirector
- Richard TraynorExecutive Officer
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶Undisclosed amountofferedSep 2021 · BiotechnologyRule 506(b)
▶Undisclosed amountofferedSep 2021 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jieun W. ChoeExecutive Officer
- Richard M. TraynorExecutive Officer
- Craig R. RaynerExecutive Officer
- Nancy KilleferDirector
- Carol G. GallagherDirector
- Eric C. LiuDirector
- Robert AspburyExecutive Officer
- Justin EdgeExecutive Officer
- Leif E. PedersenExecutive Officer
- Ethan WaxmanDirector
- Nicolette D. ShermanExecutive Officer
- Cynthia CollinsDirector
- Michael Andrew SchemickExecutive Officer
- Sherilyn S. McCoyExecutive Officer
- Mason P. SlaineDirector
- Matthew WalshDirector
- James E. Cashman IIIDirector
- Stephen M. McLeanDirector
- William F. FeeheryExecutive Officer, Director
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
How Investors Are Reacting To Certara (CERT) Expanding Buybacks Amid Wider Losses And Leadership Changes - Simply Wall St Newssimplywall.st · Aug 2026Frequently asked questions
- What does Certara do?
- Certara provides biosimulation software, modeling, and regulatory services that support drug discovery and development across discovery, preclinical, clinical, regulatory, and market access phases. It serves pharmaceutical and biotech organizations seeking to make data-driven decisions and streamline regulatory submissions.
- Who are Certara's investors?
- Certara's investors include Arsenal, Iaso Ventures.
- How much funding has Certara raised?
- Certara has disclosed $14.3M raised across 2 of its 4 known rounds.
- Where is Certara headquartered?
- Certara is headquartered in Radnor, US.